- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: her2 positive non operable breast cancer
Total 129133 results
-
Western Regional Medical CenterTerminated
-
The Affiliated Hospital of Qingdao UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
Genentech, Inc.Completed
-
Youzhi ZhuRecruitingBreast Cancer FemaleChina
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Wiseman Research Initiatives LLCTerminatedBreast Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Eisai Co., Ltd.Active, not recruiting
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2 Positive | Combination ChemotherapyChina
-
The First Affiliated Hospital with Nanjing Medical...Zhejiang Cancer HospitalRecruiting
-
Zydus Lifesciences LimitedNot yet recruiting
-
Shanghai CP Guojian Pharmaceutical Co., Ltd.CompletedMetastatic Breast CancerChina
-
Eisai Inc.Bliss Biopharmaceutical (Hangzhou) Co., LtdRecruiting
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
Zhejiang Cancer HospitalRecruitingHER2-positive Advanced Breast CancerChina
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastHong Kong, China
-
Ambrx, Inc.CompletedBreast Neoplasms | Solid Tumors | Gastric NeoplasmUnited States, Australia
-
Galena Biopharma, Inc.CompletedBreast Cancer With Low to Intermediate HER2 ExpressionUnited States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Gilead SciencesCompletedHER2 Negative Breast Carcinoma Expressing CEAFrance
-
AgendiaCompleted
-
Alteogen, Inc.Cristália Produtos Químicos Farmacêuticos Ltda.Completed
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruiting
-
Novartis PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and Neck | Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer | HER2 + Gastric CancerTaiwan, Spain, Canada, Korea, Republic of, United States
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Henan Cancer HospitalNot yet recruitingBreast Cancer | HER2-positive Breast CancerChina
-
Fudan UniversityRecruitingHER2-positive Breast CancerChina
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-positive Breast CancerChina
-
Caigang LiuJiangsu HengRui Medicine Co., Ltd.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.RecruitingHER2-positive Breast CancerUnited States
-
Xijing HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Breast Cancer
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHER2-positive Breast Cancer
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
Tianjin Hemay Pharmaceutical Co., LtdCompletedHER2 Positive Breast CancerChina
-
Novartis PharmaceuticalsActive, not recruitingAdvanced HER2+Breast CancerBelgium, France, China, Italy, Spain, Malaysia, United States, Turkey
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
University of WashingtonActive, not recruitingHER2-positive Breast CancerUnited States
-
Daiichi Sankyo, Inc.Completed
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting